Galina Likhatskaya

Dr. Galina Likhatskaya

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1996 in Toxicon
Verified
Journal Article
Closed access
VKV.I. Kalinin
V.I. Kalinin
NPN.G. Prokofieva
N.G. Prokofieva
GLGalina Likhatskaya
Galina Likhatskaya
ESE.B. Schentsova
E.B. Schentsova
IAI.G. Agafonova
I.G. Agafonova
ODO.A. Drozdova
O.A. Drozdova

1 December 2010 in Toxicon
Verified
Journal Article
Closed access
MMMargarita Mikhailovna Monastyrnaya
Margarita Mikhailovna Monastyrnaya
Elena LeychenkoElena Leychenko
Elena Leychenko
MIMarina Isaeva
Marina Isaeva
GLGalina Likhatskaya
Galina Likhatskaya
EZElena Zelepuga
Elena Zelepuga
EKEmma Kozlovskaya
Emma Kozlovskaya

1 April 2006 in Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
SKSvetlana Kovalchuk
Svetlana Kovalchuk
ESElena V. Sundukova
Elena V. Sundukova
MKMikhail I. Kusaykin
Mikhail I. Kusaykin
KGKonstantin V. Guzev
Konstantin V. Guzev
SAStanislav D. Anastiuk
Stanislav D. Anastiuk
VRValeri A. Rasskazov
Valeri A. Rasskazov

27 September 2014 in Marine Biotechnology
Verified
Journal Article
Closed access
PDF file
VGVasily Golotin
Vasily Golotin
LBLarissa Balabanova
Larissa Balabanova
GLGalina Likhatskaya
Galina Likhatskaya
VRValery Rasskazov
Valery Rasskazov

8 January 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
NKNatalya Krylova
Natalya Krylova
AKAnna O. Kravchenko
Anna O. Kravchenko
OIOlga Iunikhina
Olga Iunikhina
APAnastasiya Pott
Anastasiya Pott
GLGalina Likhatskaya
Galina Likhatskaya
IYIrina Yermak
Irina Yermak
The structural diversity and unique physicochemical properties of sulphated polysaccharides of red algae carrageenans (CRGs), to a great extent, determine the wide range of their antiviral properties. This work aimed to compare the antiviral activities of different structural types of CRGs: against herpes simplex virus type 1 (HSV-1) and enterovirus (ECHO-1). We found that CRGs significantly increased the resistance of Vero cells to virus infection (preventive effect), directly affected virus particles (virucidal effect), inhibited the attachment and penetration of virus to cells, and were more effective against HSV-1. CRG1 showed the highest virucidal effect on HSV-1 particles with a selective index (SI) of 100. CRG2 exhibited the highest antiviral activity by inhibiting HSV-1 and ECHO-1 plaque formation, with a SI of 110 and 59, respectively, when it was added before virus infection. CRG2 also significantly reduced the attachment of HSV-1 and ECHO-1 to cells compared to other CRGs. It was shown by molecular docking that tetrasaccharides—CRGs are able to bind with the HSV-1 surface glycoprotein, gD, to prevent virus–cell interactions. The revealed differences in the effect of CRGs on different stages of the lifecycle of the viruses are apparently related to the structural features of the investigated compounds.

15 October 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
NKNatalya Krylova
Natalya Krylova
ASArtem Silchenko
Artem Silchenko
APAnastasiya Pott
Anastasiya Pott
SESvetlana Ermakova
Svetlana Ermakova
OIOlga Iunikhina
Olga Iunikhina
Mikhail Yurievich ShchelkanovMikhail Yurievich Shchelkanov
Mikhail Yurievich Shchelkanov
The Hantaan orthohantavirus (genovariant Amur–AMRV) is a rodent-borne zoonotic virus; it is the causative agent of haemorrhagic fever with renal syndrome in humans. The currently limited therapeutic options require the development of effective anti-orthohantavirus drugs. The ability of native fucoidan from Fucus evanescens (FeF) and its enzymatically prepared high-molecular-weight (FeHMP) and low-molecular-weight (FeLMP) fractions to inhibit different stages of AMRV infection in Vero cells was studied. The structures of derivatives obtained were determined using nuclear magnetic resonance (NMR) spectroscopy. We found that fucoidan and its derivatives exhibited significant antiviral activity by affecting the early stages of the AMRV lifecycle, notably virus attachment and penetration. The FeHMP and FeLMP fractions showed the highest anti-adsorption activity by inhibiting AMRV focus formation, with a selective index (SI) > 110; FeF had an SI of ~70. The FeLMP fraction showed a greater virucidal effect compared with FeF and the FeHMP fraction. It was shown by molecular docking that 2O-sulphated fucotetrasaccharide, a main component of the FeLMP fraction, is able to bind with the AMRV envelope glycoproteins Gn/Gc and with integrin β3 to prevent virus–cell interactions. The relatively small size of these sites of interactions explains the higher anti-AMRV activity of the FeLMP fraction.